Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study-Reference-Cited by-同舟云学术

Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Published:2015-01-22 Issue:8 Volume:21 Page:1896-1903
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Besse Benjamin,Le Moulec Sylvestre,Mazières Julien,Senellart Hélène,Barlesi Fabrice,Chouaid Christos,Dansin Eric,Bérard Henri,Falchero Lionel,Gervais Radj,Robinet Gilles,Ruppert Anne-Marie,Schott Roland,Léna Hervé,Clément-Duchêne Christelle,Quantin Xavier,Souquet Pierre Jean,Trédaniel Jean,Moro-Sibilot Denis,Pérol Maurice,Madroszyk Anne-Catherine,Soria Jean-Charles

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents;Cancer Immunology, Immunotherapy;2024-09-06

3. Machine learning-driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset;Clinical and Translational Oncology;2024-04-03

4. Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy;Clinical and Translational Oncology;2024-03-13

5. Survival prediction using apparent diffusion coefficient values in recurrent glioblastoma under bevacizumab treatment: an updated systematic review and meta-analysis;Diagnostic and Interventional Radiology;2024-02-01